Zobrazeno 1 - 10
of 38
pro vyhledávání: '"R R, Hantgan"'
Publikováno v:
Blood Coagulation & Fibrinolysis. 5:233-238
Routine laboratory screening identified an abnormal fibrinogen in an asymptomatic patient from New Britain, Connecticut. This paper reports the characterization of the abnormal fibrinogen. Clinical clotting studies showed marked prolongation of both
Autor:
R R, Hantgan, M, Stahle, V, Del Gaizo, M, Adams, T, Lasher, W G, Jerome, M, McKenzie, D S, Lyles
Publikováno v:
Biochimica et biophysica acta. 1540(1)
The platelet integrin alphaIIbbeta3 exhibits bidirectional signaling, in that intracellular messengers enable adhesive macromolecules to bind to its ectodomain, while ligation promotes the association of cytoskeletal proteins with its cytoplasmic dom
Publikováno v:
Annals of the New York Academy of Sciences. 936
B beta Arg166 to Cys substitution was identified in an abnormal fibrinogen named fibrinogen Longmont. The proband, a young woman, and her mother were heterozygous; both experienced episodes of severe hemorrhage at childbirth. The neo-Cys residues wer
Publikováno v:
Journal of lipid research. 42(2)
Apolipoprotein (apo)A-IV is synthesized in the small intestine during fat absorption and is incorporated onto the surface of nascent chylomicrons. In circulation, apoA-IV is displaced from the chylomicron surface by high density lipoprotein-associate
Publikováno v:
The Journal of biological chemistry. 275(23)
We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissingen/Frankfurt IV, a deletion of two residues, gammaAsn-319 and gammaAsp-320, located within the high affinity calcium-binding pocket. Turbidity studi
Publikováno v:
Blood. 92(6)
The purpose of this study was to establish the effects of clot age and thrombolysis, with either streptokinase or tissue-type plasminogen activator (tPA), on argatroban's ability to inhibit thrombin. The antithrombotic activity of argatroban has been
Publikováno v:
Thrombosis and haemostasis. 79(3)
The molecular and cellular mechanisms that over a period of hours render a human thrombus progressively resistant to fibrinolysis have been probed with a novel in vitro model. The kinetics of clot formation and fibrinolysis were monitored by laser li
Publikováno v:
Blood. 87(10)
Time-dependent thrombolytic resistance is a critical problem in thrombolytic therapy for acute myocardial infarction. Platelets have been regarded as the main source of plasminogen activator inhibitor-1 (PAI-1) found in occlusive platelet-rich clots.
Publikováno v:
Microscopy and Microanalysis. 10:1402-1403
Extended abstract of a paper presented at Microscopy and Microanalysis 2004 in Savannah, Georgia, USA, August 1–5, 2004.
Autor:
S C, Endenburg, R R, Hantgan, L, Lindeboom-Blokzijl, H, Lankhof, W G, Jerome, J C, Lewis, J J, Sixma, P G, de Groot
Publikováno v:
Blood. 86(11)
Platelet adhesion to fibrin at high shear rates depends on both the glycoprotein (GP) IIb:IIIa complex and a secondary interaction between GPIb and von Willebrand factor (vWF). This alternative link between platelets and vWF in promoting platelet adh